Bronchoscopy in the post-acute phase of COVID-19: an observational study.
COVID-19 sequelae
Long COVID
Lung cancer
Tracheal stenosis
Tracheostomy; Bronchoscopy
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
22 May 2023
22 May 2023
Historique:
received:
07
03
2023
accepted:
14
05
2023
medline:
24
5
2023
pubmed:
23
5
2023
entrez:
22
5
2023
Statut:
epublish
Résumé
Bronchoscopy is a useful technique adopted in the management of patients with COVID-19. 10-40% of COVID-19 survivors experience persistent symptoms. A comprehensive description of the utility and safety of bronchoscopy in the management of patients with COVID-19 sequelae is lacking. The aim of the study was to evaluate the role of bronchoscopy in patients with suspected post-acute sequelae of COVID-19. An observational, retrospective study was carried out in Italy. Patients requiring bronchoscopy for suspected COVID-19 sequelae were enrolled. 45 (21, 46.7%, female) patients were recruited. Bronchoscopy was more frequently indicated for patients with a previous critical disease. The most frequent indications were tracheal complications, mostly performed in patients who were hospitalized during the acute phase than treated at home (14, 48.3% VS. 1, 6.3%; p-value: 0.007) and persistent parenchymal infiltrates, more frequent in those treated at home (9, 56.3% VS. 5, 17.2%; p-value: 0.008). 3 (6.6%) patients after the first bronchoscopy required higher oxygen flow. Four patients were diagnosed with lung cancer. Bronchoscopy is a useful and safe technique in patients with suspected post-acute sequelae of COVID-19. The severity of acute disease plays a role in the rate and indications of bronchoscopy. Endoscopic procedures were mostly performed for tracheal complications in critical, hospitalized patients and for persistent lung parenchymal infiltrates in mild-moderate infections treated at home.
Sections du résumé
BACKGROUND
BACKGROUND
Bronchoscopy is a useful technique adopted in the management of patients with COVID-19. 10-40% of COVID-19 survivors experience persistent symptoms. A comprehensive description of the utility and safety of bronchoscopy in the management of patients with COVID-19 sequelae is lacking. The aim of the study was to evaluate the role of bronchoscopy in patients with suspected post-acute sequelae of COVID-19.
METHODS
METHODS
An observational, retrospective study was carried out in Italy. Patients requiring bronchoscopy for suspected COVID-19 sequelae were enrolled.
RESULTS
RESULTS
45 (21, 46.7%, female) patients were recruited. Bronchoscopy was more frequently indicated for patients with a previous critical disease. The most frequent indications were tracheal complications, mostly performed in patients who were hospitalized during the acute phase than treated at home (14, 48.3% VS. 1, 6.3%; p-value: 0.007) and persistent parenchymal infiltrates, more frequent in those treated at home (9, 56.3% VS. 5, 17.2%; p-value: 0.008). 3 (6.6%) patients after the first bronchoscopy required higher oxygen flow. Four patients were diagnosed with lung cancer.
CONCLUSION
CONCLUSIONS
Bronchoscopy is a useful and safe technique in patients with suspected post-acute sequelae of COVID-19. The severity of acute disease plays a role in the rate and indications of bronchoscopy. Endoscopic procedures were mostly performed for tracheal complications in critical, hospitalized patients and for persistent lung parenchymal infiltrates in mild-moderate infections treated at home.
Identifiants
pubmed: 37217883
doi: 10.1186/s12890-023-02477-6
pii: 10.1186/s12890-023-02477-6
pmc: PMC10202063
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
178Informations de copyright
© 2023. The Author(s).
Références
Lancet. 2020 Aug 1;396(10247):320-332
pubmed: 32682491
PLoS One. 2020 Nov 11;15(11):e0240347
pubmed: 33175876
Eur Respir J. 2022 Aug 4;60(2):
pubmed: 35144991
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
J Laryngol Otol. 2021 Jul;135(7):656-658
pubmed: 33973511
Radiology. 2021 Nov;301(2):E383-E395
pubmed: 34374591
BMC Infect Dis. 2022 Sep 29;22(1):760
pubmed: 36175841
JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):70-76
pubmed: 33211087
J Clin Med. 2022 Mar 20;11(6):
pubmed: 35330044
Infect Dis (Lond). 2022 Feb;54(2):134-144
pubmed: 34606393
Respir Care. 2022 Feb;67(2):241-251
pubmed: 34848547
ERJ Open Res. 2021 Jul 12;7(3):
pubmed: 34258257
Tomography. 2022 Apr 20;8(3):1184-1195
pubmed: 35645383
Front Med (Lausanne). 2022 Jul 14;9:897990
pubmed: 35911414
Pulmonology. 2022 Nov-Dec;28(6):461-471
pubmed: 32624385
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399
pubmed: 32603803
Sci Rep. 2021 Nov 22;11(1):22666
pubmed: 34811387
Respir Res. 2020 Jun 29;21(1):163
pubmed: 32600344
Eur Respir J. 2021 Aug 26;58(2):
pubmed: 33926969
Respir Med. 2021 Oct;187:106577
pubmed: 34416618
Eur Respir J. 2020 Oct 15;56(4):
pubmed: 32859682
Front Oncol. 2021 Aug 16;11:693002
pubmed: 34485128